China
Africa
Explore chapters and articles related to this topic
Oral Nutritional Supplements and Appetite Stimulation Therapy
Published in Michael M. Rothkopf, Jennifer C. Johnson, Optimizing Metabolic Status for the Hospitalized Patient, 2023
Michael M. Rothkopf, Jennifer C. Johnson
Appetite suppression is a known side effect of certain medications. A review of the patient’s medication profile should be performed. Withdrawal of the potentially offending drugs should be considered. The medications most commonly associated with anorexia include adrenergic stimulants (including decongestants), anticholinergics, certain antibiotics and antivirals, anticonvulsants (such as topiramate), opiates, hormones (i.e., estrogen and thyroxine) and theophylline (Goldberg, Kaplan, and Boucher 2005).
Current issues in understanding sexual victimization
Published in Rachel E. Lovell, Jennifer Langhinrichsen-Rohling, Sexual Assault Kits and Reforming the Response to Rape, 2023
The issue of trauma and memory has been long debated and studied in the literature (see Crespo & Fernandez-Lansac, 2016 for a review). Issues of false memory, suggestibility, and recall have been studied and written about extensively (e.g., Brainerd & Reyna, 2005; Williams & Banyard, 1999). Traumatic events are associated with periods of forgetting or failure to recall the event at all, called traumatic amnesia, in a significant percentage of victims (American Psychiatric Association, 2013). Psychological defenses of denial, dissociation, depersonalization, and repression/suppression impact memory as well. These defenses disrupt the normal integration of cognitive function, including memory, perception, consciousness, and behavior, often following a traumatic event (American Psychiatric Association, 2013).
Cystic Fibrosis and Pancreatic Disease
Published in Praveen S. Goday, Cassandra L. S. Walia, Pediatric Nutrition for Dietitians, 2022
Elissa M. Downs, Jillian K. Mai, Sarah Jane Schwarzenberg
The medication list should be carefully reviewed to determine potential effects on appetite and growth. It is important to recognize medications that may be used off-label as appetite stimulants (including, but not limited to cyproheptadine, mirtazapine, megestrol acetate, dronabinol) or medications with weight gain as possible side effects (corticosteroids, new highly effective CFTR modulators, certain antidepressants). Medications may also contribute to appetite suppression (stimulant medications for attention-deficit hyperactivity disorder, certain antidepressants, metformin) or affect taste or sense of smell (antibiotics, antifungals, antivirals, antihistamines, bronchodilators, thyroid hormone, diuretics). The primary CF therapy should be noted; if the patient is on one of the CFTR modulators (Table 19.3), these should be taken with fat (recommendations vary between 10 and 20 g/dose) and PERT to optimize absorption.
Systemic Immunosuppression in Cornea and Ocular Surface Disorders: A Ready Reckoner for Ophthalmologists
Published in Seminars in Ophthalmology, 2022
The suppression of the immune system as a therapeutic modality has long been adopted by clinicians of various disciplines. In the field of ophthalmology, this is done primarily by those dealing with uveitis and its myriad presentations. However, for the general ophthalmologist or one predominantly dealing with anterior segment pathologies there is a certain hesitance bordering on reluctance, to initiate these medications. This occurs probably because the literature regarding the indications, dosage regimes, side effects, etc. of this group of drugs is vast, largely inconclusive and more importantly spread apart in space. This writeup aims to provide a brief overview of the different options available should one want to start a patient on immunosuppressive agents and the different disorders wherein these medications are most likely to be needed. The various follow-up regimens and the expected side effects that treating physician should look out for have also been summarized (Table 1).
The associations of dispositional mindfulness, self-compassion, and reappraisal with symptoms of depression and anxiety among a sample of Indigenous students in Canada
Published in Journal of American College Health, 2021
Saghar Chahar Mahali, Shadi Beshai, Whitney L. Wolfe
In addition to mindfulness and self-compassion, several other emotion regulation strategies are used and promoted in Western interventions of anxiety and depression, unfortunately with little scientific support for their use to alleviate symptoms of these conditions among non-White participants.35 Cognitive reappraisal and emotional suppression are two widely studied emotion regulation strategies.36,37 Cognitive reappraisal is defined as the reinterpretation of emotionally eliciting materials or events in a way that alters the emotional response.36 Suppression is defined as a person’s attempt to decrease emotional expression of a certain emotion and/or their attempt to decrease or eliminate thoughts or discussions of this said emotion.38
Emotion Regulation Patterns among Colorectal Cancer Survivors: Clustering and Associations with Personal Coping Resources
Published in Behavioral Medicine, 2021
Svetlana Baziliansky, Miri Cohen
Suppression, in contrast, is defined as a deliberate and conscious effort to avoid thinking about or expressing negative emotions and emotion-expressive behavior,9,12 while sympathetic system reactions are increased.13 Hence, suppression differs from repression in that suppressors acknowledge that their negative emotions exist yet consciously inhibit themselves from experiencing or expressing these emotions.8 Unlike repression, which was found to be related to lower levels of reported psychological distress (anxiety and depression),10 suppression can paradoxically enhance unpleasant emotional reactions.4,14 Like repression, suppression is often considered to be a personal tendency.9,15